Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01922778 · ClinicalTrials.gov registry record · NA
Screening for Endometrial Abnormalities in Overweight and Obese Women
A NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- NA
- Development phase
- 303
- Enrollment target
NCT01922778 is a NA study that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 303 participants.
The verdict
NCT01922778, a NA study, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 303 participants
- Enrollment target
Study Summary
The purpose of this study is to develop an endometrial biopsy screening program for endometrial cancer and its precursor lesions in overweight and obese women. There is a BMI threshold at and above which optimal screening parameters exist for identifying endometrial cancer and its precursor lesions in overweight and/or obese women. Prevention, diagnosis and treatment of endometrial cancer and its precursor lesions in overweight and/or obese women offers substantial health benefits.
Interventions
- PROCEDURE Endometrial Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01922778
The ClinicalTrials.gov registry entry for NCT01922778 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endometrial Biopsy is the first listed.
NCT01922778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01922778 about?
NCT01922778 is a clinical study titled "Screening for Endometrial Abnormalities in Overweight and Obese Women". The purpose of this study is to develop an endometrial biopsy screening program for endometrial cancer and its precursor lesions in overweight and obese women. There is a BMI threshold at and above which optimal screening parameters exist for identifying endometrial cancer and its precursor lesions...
What is the current status of trial NCT01922778?
This trial is currently completed. It is a NA study. The enrollment target is 303 participants. The study started on 2013-09. Estimated completion is 2016-03-31.
What interventions are being tested in trial NCT01922778?
The interventions under investigation include: Endometrial Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01922778?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.